advertisement

Topcon

Foster PJ 49

Showing records 1 to 25 | Display all abstracts from Foster PJ

112704 Calcium Channel Blocker Use and Associated Glaucoma and Related Traits Among UK Biobank Participants
Kastner A
JAMA ophthalmology 2023; 141: 956-964
111836 Deep Ocular Phenotyping Across Primary Open-Angle Glaucoma Genetic Burden
Sekimitsu S
JAMA ophthalmology 2023; 141: 891-899
112526 Role of Static and Dynamic Ocular Biometrics Measured in the Dark and Light as Risk Factors for Angle Closure Progression
Cho A
American Journal of Ophthalmology 2023; 256: 27-34
112150 Technologies for the diagnosis of angle closure glaucoma (ACE): protocol of a prospective, multicentre, cross-sectional diagnostic study
Azuara-Blanco A
BMJ open 2023; 13: e073975
112704 Calcium Channel Blocker Use and Associated Glaucoma and Related Traits Among UK Biobank Participants
Stuart KV
JAMA ophthalmology 2023; 141: 956-964
112150 Technologies for the diagnosis of angle closure glaucoma (ACE): protocol of a prospective, multicentre, cross-sectional diagnostic study
Lawrenson JG
BMJ open 2023; 13: e073975
111836 Deep Ocular Phenotyping Across Primary Open-Angle Glaucoma Genetic Burden
Xiang D
JAMA ophthalmology 2023; 141: 891-899
112526 Role of Static and Dynamic Ocular Biometrics Measured in the Dark and Light as Risk Factors for Angle Closure Progression
Xu BY; Friedman DS
American Journal of Ophthalmology 2023; 256: 27-34
112704 Calcium Channel Blocker Use and Associated Glaucoma and Related Traits Among UK Biobank Participants
Montesano G
JAMA ophthalmology 2023; 141: 956-964
111836 Deep Ocular Phenotyping Across Primary Open-Angle Glaucoma Genetic Burden
Smith SL
JAMA ophthalmology 2023; 141: 891-899
112150 Technologies for the diagnosis of angle closure glaucoma (ACE): protocol of a prospective, multicentre, cross-sectional diagnostic study
King AJ
BMJ open 2023; 13: e073975
111836 Deep Ocular Phenotyping Across Primary Open-Angle Glaucoma Genetic Burden
Curran K
JAMA ophthalmology 2023; 141: 891-899
112704 Calcium Channel Blocker Use and Associated Glaucoma and Related Traits Among UK Biobank Participants
De Moraes CG
JAMA ophthalmology 2023; 141: 956-964
112526 Role of Static and Dynamic Ocular Biometrics Measured in the Dark and Light as Risk Factors for Angle Closure Progression
Foster PJ
American Journal of Ophthalmology 2023; 256: 27-34
112704 Calcium Channel Blocker Use and Associated Glaucoma and Related Traits Among UK Biobank Participants
De Moraes CG; De Moraes CG
JAMA ophthalmology 2023; 141: 956-964
112150 Technologies for the diagnosis of angle closure glaucoma (ACE): protocol of a prospective, multicentre, cross-sectional diagnostic study
Foster PJ
BMJ open 2023; 13: e073975
112704 Calcium Channel Blocker Use and Associated Glaucoma and Related Traits Among UK Biobank Participants
De Moraes CG
JAMA ophthalmology 2023; 141: 956-964
112150 Technologies for the diagnosis of angle closure glaucoma (ACE): protocol of a prospective, multicentre, cross-sectional diagnostic study
Virgili G
BMJ open 2023; 13: e073975
112704 Calcium Channel Blocker Use and Associated Glaucoma and Related Traits Among UK Biobank Participants
Kang JH
JAMA ophthalmology 2023; 141: 956-964
111836 Deep Ocular Phenotyping Across Primary Open-Angle Glaucoma Genetic Burden
Elze T
JAMA ophthalmology 2023; 141: 891-899
112526 Role of Static and Dynamic Ocular Biometrics Measured in the Dark and Light as Risk Factors for Angle Closure Progression
Pardeshi AA
American Journal of Ophthalmology 2023; 256: 27-34
111836 Deep Ocular Phenotyping Across Primary Open-Angle Glaucoma Genetic Burden
Friedman DS
JAMA ophthalmology 2023; 141: 891-899
112150 Technologies for the diagnosis of angle closure glaucoma (ACE): protocol of a prospective, multicentre, cross-sectional diagnostic study
Guiney M
BMJ open 2023; 13: e073975
112704 Calcium Channel Blocker Use and Associated Glaucoma and Related Traits Among UK Biobank Participants
Wiggs JL
JAMA ophthalmology 2023; 141: 956-964
112150 Technologies for the diagnosis of angle closure glaucoma (ACE): protocol of a prospective, multicentre, cross-sectional diagnostic study
Nolan W
BMJ open 2023; 13: e073975

Issue 24-3

Change Issue


advertisement

Oculus